Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Bibliographic Details
Main Authors:	Lee, Jung Min, Jang, Byoung Kuk, Lee, Yoo Jin, Choi, Wang Yong, Choi, Sei Myong, Chung, Woo Jin, Hwang, Jae Seok, Kang, Koo Jeong, Kim, Young Hwan, Chauhan, Anil Kumar, Park, Soo Young, Tak, Won Young, Kweon, Young Oh, Kim, Byung Seok, Lee, Chang Hyeong
Format:	Online
Language:	English
Published:	The Korean Association for the Study of the Liver 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825165/

Similar Items

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
by: SHAO, WENBO, et al.
Published: (2014)

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
by: Park, Kil Hyo, et al.
Published: (2015)

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
by: Jang, Ji Hye, et al.
Published: (2015)

Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study
by: Hu, Hao, et al.
Published: (2014)

Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
by: Jeong, Soung Won, et al.
Published: (2013)

Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma: A case report
by: Kim, Shin Il, et al.
Published: (2016)

Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
by: Kang, Ja Young, et al.
Published: (2010)

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
by: Song, Myeong Jun, et al.
Published: (2016)

Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
by: Jeong, Yuri, et al.
Published: (2015)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
by: Zheng, Ninggang, et al.
Published: (2016)

DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study
by: Song, Do Seon, et al.
Published: (2013)

A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
by: Kim, Hee Yeon, et al.
Published: (2010)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Kim, Jun Young, et al.
Published: (2016)

Use of 18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
by: Kim, Min Jin, et al.
Published: (2015)

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study
by: Cho, Youn Zoo, et al.
Published: (2015)

Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
by: Yang, Biao, et al.
Published: (2016)

Computed Tomographic-Guided Radiofrequency Ablation of Recurrent or Residual Hepatocellular Carcinomas around Retained Iodized Oil after Transarterial Chemoembolization
by: Koh, Young Hwan, et al.
Published: (2013)

Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy
by: Park, Hana, et al.
Published: (2010)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
by: Kloeckner, Roman, et al.
Published: (2015)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur, Johannes, et al.
Published: (2016)

Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?
by: Kang, Hyo-Jin, et al.
Published: (2015)

An early single-center experience of portal vein thrombosis in living donor liver transplantation: clinical feature, management and outcome
by: Kim, Joo Dong, et al.
Published: (2011)

Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
by: Zhang, Leida, et al.
Published: (2014)

Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Lin Li, et al.
Published: (2018-09-01)

Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
by: Shuling Chen, et al.
Published: (2018-04-01)

The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization
by: Liu, Lei, et al.
Published: (2016)

Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study
by: Hsiao, Wang-De, et al.
Published: (2016)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
by: Zhang, Yong-Fa, et al.
Published: (2016)

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
by: Lee, Yong Kang, et al.
Published: (2013)

Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients
by: Liu, Lei, et al.
Published: (2014)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen, Waleed, et al.
Published: (2017)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
by: Shin, Sung Wook
Published: (2009)

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
by: Nam, Hee Chul, et al.
Published: (2016)

A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
by: Kim, Ah ran, et al.
Published: (2015)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Woo, Hyun Young, et al.
Published: (2015)

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
by: Kim, Kyung Hoon, et al.
Published: (2011)

Follow-up results of acute portal and splenic vein thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery
by: Cho, Chan Woo, et al.
Published: (2015)

Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
by: Sohn, Won, et al.
Published: (2014)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization
by: Chu, Hai-Jui, et al.
Published: (2015)

Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
by: Xue, Tong-Chun, et al.
Published: (2013)